Candida albicans-specific mucosal CD4+ T cell clones
白色念珠菌特异性粘膜 CD4 T 细胞克隆
基本信息
- 批准号:6785445
- 负责人:
- 金额:$ 14.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:Candida albicansantibody specificitycell population studycellular immunityclone cellscolony stimulating factorflow cytometryhelper T lymphocytehost organism interactionlaboratory mouselight microscopymicroorganism culturemicroorganism growthmolecular cloningopportunistic infectionsoral bacteriaoral mucosapathologic processsingle cell analysistissue /cell preparation
项目摘要
DESCRIPTION (provided by applicant):
Candida albicans is a commensal that colonizes skin and mucosal surfaces including the oral cavity. The organism forms biofilms on mucosa and oral devices, e.g. dentures, generally in association with bacteria. The organism is also an agent of opportunistic infection of these surfaces as well as disseminated disease. Among individuals that are most susceptible to oral infection are HIV+ patients who have declining CD4+ T cells. The correlation between loss of this lymphocyte population and disease implicates CD4+ T cells in protection of the healthy individual from disease. CD4+ T cells have also been implicated in susceptibility in murine models of infection. While T-helper 1 type cell-mediated immunity (CMI) has been implicated in protection and recovery from both systemic and mucosal infection, it is also clear that mucosal and systemic immune response has elements of compartmentalization. This is emphasized by the susceptibility of the AIDS patient to oral mucosal but not systemic disease. The profile of T cells in the oral mucosa differs from that of peripheral blood. In recent years, T cells clones have been a useful tool to identify the specific antigens and their epitopes that stimulate the CMI response. However, the application of these protocols has been applied to lymphocytes of peripheral circulation and not those of the oral mucosa that are important in the response to oral pathogens. The goal of this proposal is to establish procedures for isolating CD4+ T cell clones that are derived from the T cell population of the oral mucosa in mice colonized with C. albicans. The successful development of this protocol has specific application that will provide a major tool for subsequent studies of host response and control of oral C. albicans. A successful protocol will also have more widespread application to study the mucosal response to components of the normal oral flora and agents of oral infection.
描述(由申请人提供):
白色念珠菌是一个共同的,它在包括口腔在内的皮肤和粘膜表面定居。该生物体在粘膜和口服装置上形成生物膜,例如假牙,通常与细菌相关。生物体也是这些表面和传播疾病的机会感染的推动者。在最容易感染口腔感染的个体中,CD4+ T细胞下降的HIV+患者。这种淋巴细胞群体和疾病的丧失之间的相关性暗示了CD4+ T细胞在保护健康个体免受疾病的保护方面。 CD4+ T细胞也与鼠类感染模型中的敏感性有关。虽然T-助血器1型细胞介导的免疫(CMI)与全身性和粘膜感染的保护和恢复有关,但也很明显,粘膜和全身免疫反应具有分隔的元素。艾滋病患者对口腔粘膜的敏感性而不是全身性疾病,这强调了这一点。口服粘膜中T细胞的特征与外周血的特征不同。近年来,T细胞克隆成为识别刺激CMI反应的特定抗原及其表位的有用工具。但是,这些方案的应用已应用于外周循环的淋巴细胞,而不是口服粘膜的淋巴细胞,而不是对口腔病原体反应的重要性。该提案的目的是建立分离源自白色念珠菌定植的小鼠口服粘膜T细胞群体的CD4+ T细胞克隆的程序。该协议的成功开发具有特定的应用,该应用将为随后研究宿主反应和口服白色念珠菌的控制提供主要工具。成功的方案还将有更多的广泛应用来研究对正常口腔菌群和口腔感染药物的粘膜反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Welda LaJean CHAFFIN其他文献
Welda LaJean CHAFFIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Welda LaJean CHAFFIN', 18)}}的其他基金
7th ASM Conference on Candida and Candidiasis
第七届 ASM 念珠菌和念珠菌病会议
- 批准号:
6770757 - 财政年份:2004
- 资助金额:
$ 14.8万 - 项目类别:
Candida albicans-specific mucosal CD4+ T cell clones
白色念珠菌特异性粘膜 CD4 T 细胞克隆
- 批准号:
6655419 - 财政年份:2003
- 资助金额:
$ 14.8万 - 项目类别:
A proteomics approach to Candida albicans biofilm
白色念珠菌生物膜的蛋白质组学方法
- 批准号:
6782705 - 财政年份:2003
- 资助金额:
$ 14.8万 - 项目类别:
A proteomics approach to Candida albicans biofilm
白色念珠菌生物膜的蛋白质组学方法
- 批准号:
6906516 - 财政年份:2003
- 资助金额:
$ 14.8万 - 项目类别:
A proteomics approach to Candida albicans biofilm
白色念珠菌生物膜的蛋白质组学方法
- 批准号:
6696099 - 财政年份:2003
- 资助金额:
$ 14.8万 - 项目类别:
6th ASM Conference on Candida and Candidiasis
第六届 ASM 念珠菌和念珠菌病会议
- 批准号:
6459227 - 财政年份:2002
- 资助金额:
$ 14.8万 - 项目类别:
相似国自然基金
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
双特异性抗体囊泡对胞内细菌感染的免疫综合机制研究
- 批准号:82304366
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于群体感应实现瘤内特异性免疫激活与PD1抗体递送的活体细菌药物及其抗癌机制研究
- 批准号:82303774
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于OX40激动剂抗体耐药机制的联合用药策略和双特异性抗体设计
- 批准号:82373898
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
AuNPs@CTLA-4/Nb16-Fc多臂纳米抗体增强DC/肿瘤融合疫苗诱导特异性CTL抗癌研究
- 批准号:82360559
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 14.8万 - 项目类别:
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer
肿瘤衍生新表位的自身抗体作为生物标志物和免疫 PET 试剂用于小细胞肺癌的早期检测
- 批准号:
10715807 - 财政年份:2023
- 资助金额:
$ 14.8万 - 项目类别:
Immunogenicity of the dengue vaccine CYD-TDV in a dengue virus serotype 1 immune population
登革热疫苗 CYD-TDV 在登革热病毒血清型 1 免疫群体中的免疫原性
- 批准号:
10728086 - 财政年份:2023
- 资助金额:
$ 14.8万 - 项目类别:
Multiplex Ultrasound Imaging for the Detection of Head and Neck Lymph Node Micrometastases
用于检测头颈部淋巴结微转移的多重超声成像
- 批准号:
10870266 - 财政年份:2023
- 资助金额:
$ 14.8万 - 项目类别:
Pharmacokinetic / Pharmacodynamic Optimization of ADC Therapy for Acute Myeloid Leukemia
急性髓系白血病 ADC 治疗的药代动力学/药效学优化
- 批准号:
10561230 - 财政年份:2023
- 资助金额:
$ 14.8万 - 项目类别: